Giuliani SpA

Focuses on gastroenterology and dermatology. It is currently marketing patented products for the treatment and management of ulcerative colitis, Crohn's disease, food intolerances, and skin conditions. Giuliani SpA's R&D pipeline includes new chemical entities and biotech products aimed at treating inflammatory and autoimmune diseases.